The current WHO classification of lymphoid neoplasms further subdivides systemic ALCL into anaplastic lymphoma kinase ALK-positive (6.6%) and ALK-negative (5.5%), according to ALK protein expression in tumor samples [3]. The gene discussed is ALK; the disease is lymphoid neoplasm.